NCT07162181 2026-04-17Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood CancersEli Lilly and CompanyPhase 2 Active not recruiting13 enrolled
NCT04849416 2026-02-06A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)Eli Lilly and CompanyPhase 2 Completed87 enrolled 19 charts